Advisors Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,361
Closed -$1.35M 1512
2021
Q2
$1.35M Sell
7,361
-104
-1% -$19.1K 0.02% 720
2021
Q1
$1.14M Sell
7,465
-3,273
-30% -$500K 0.02% 784
2020
Q4
$1.68M Buy
10,738
+619
+6% +$96.7K 0.03% 623
2020
Q3
$1.16M Sell
10,119
-438
-4% -$50.1K 0.02% 664
2020
Q2
$1.19M Sell
10,557
-493
-4% -$55.3K 0.02% 641
2020
Q1
$992K Sell
11,050
-4,926
-31% -$442K 0.02% 619
2019
Q4
$1.73M Sell
15,976
-1,690
-10% -$183K 0.03% 575
2019
Q3
$1.73M Sell
17,666
-2,826
-14% -$277K 0.03% 575
2019
Q2
$2.68M Buy
20,492
+1,790
+10% +$234K 0.05% 445
2019
Q1
$2.53M Sell
18,702
-1,027
-5% -$139K 0.05% 461
2018
Q4
$1.92M Buy
19,729
+59
+0.3% +$5.75K 0.04% 515
2018
Q3
$2.73M Buy
19,670
+1,242
+7% +$173K 0.04% 472
2018
Q2
$2.29M Buy
18,428
+3,572
+24% +$443K 0.04% 558
2018
Q1
$1.75M Buy
14,856
+604
+4% +$70.9K 0.03% 640
2017
Q4
$1.7M Buy
14,252
+2,147
+18% +$257K 0.03% 666
2017
Q3
$1.7M Sell
12,105
-1,640
-12% -$230K 0.03% 660
2017
Q2
$1.67M Buy
13,745
+198
+1% +$24.1K 0.03% 693
2017
Q1
$1.64M Sell
13,547
-3,915
-22% -$475K 0.03% 700
2016
Q4
$2.14M Sell
17,462
-477
-3% -$58.3K 0.04% 614
2016
Q3
$2.2M Sell
17,939
-4,608
-20% -$565K 0.04% 598
2016
Q2
$2.63M Sell
22,547
-2,511
-10% -$293K 0.04% 567
2016
Q1
$3.49M Sell
25,058
-11,179
-31% -$1.56M 0.06% 464
2015
Q4
$6.91M Sell
36,237
-655
-2% -$125K 0.11% 260
2015
Q3
$5.77M Sell
36,892
-2,846
-7% -$445K 0.09% 303
2015
Q2
$7.18M Buy
39,738
+819
+2% +$148K 0.1% 275
2015
Q1
$6.75M Sell
38,919
-6,406
-14% -$1.11M 0.09% 281
2014
Q4
$8.39M Sell
45,325
-1,710
-4% -$316K 0.11% 231
2014
Q3
$7.8M Buy
47,035
+1,121
+2% +$186K 0.11% 235
2014
Q2
$7.17M Buy
45,914
+7,133
+18% +$1.11M 0.1% 252
2014
Q1
$5.9M Buy
38,781
+8,450
+28% +$1.29M 0.09% 284
2013
Q4
$4.04M Buy
30,331
+6,558
+28% +$873K 0.07% 358
2013
Q3
$2.76M Sell
23,773
-227
-0.9% -$26.4K 0.05% 418
2013
Q2
$2.21M Buy
+24,000
New +$2.21M 0.04% 442